Page last updated: 2024-10-27

flurbiprofen and Cancer of Head

flurbiprofen has been researched along with Cancer of Head in 3 studies

Flurbiprofen: An anti-inflammatory analgesic and antipyretic of the phenylalkynoic acid series. It has been shown to reduce bone resorption in periodontal disease by inhibiting CARBONIC ANHYDRASE.
flurbiprofen : A monocarboxylic acid that is a 2-fluoro-[1,1'-biphenyl-4-yl] moiety linked to C-2 of propionic acid. A non-steroidal anti-inflammatory, analgesic and antipyretic, it is used as a pre-operative anti-miotic as well as orally for arthritis or dental pain.

Research Excerpts

ExcerptRelevanceReference
"The paper is to report the establishment of a population pharmacokinetic model for flurbiprofen (FP), an active metabolite of flurbiprofen axetil (FA)."1.36[Population pharmacokinetic modeling of flurbiprofen]. ( Gong, SJ; Huang, PF; Lin, WW; Wang, CL, 2010)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Wang, CL1
Lin, WW1
Gong, SJ1
Huang, PF1
Stokman, MA1
Spijkervet, FK1
Burlage, FR1
Roodenburg, JL1
Brieger, J1
Schroeder, P1
Gosepath, J1
Mann, WJ1

Other Studies

3 other studies available for flurbiprofen and Cancer of Head

ArticleYear
[Population pharmacokinetic modeling of flurbiprofen].
    Yao xue xue bao = Acta pharmaceutica Sinica, 2010, Volume: 45, Issue:11

    Topics: Adult; Aged; Analgesics; Body Weight; Female; Flurbiprofen; Head and Neck Neoplasms; Humans; Injecti

2010
Clinical effects of flurbiprofen tooth patch on radiation-induced oral mucositis. A pilot study.
    Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 2005, Volume: 13, Issue:1

    Topics: Aged; Anti-Inflammatory Agents, Non-Steroidal; Carcinoma, Squamous Cell; Female; Flurbiprofen; Head

2005
The cyclooxygenase inhibitor flurbiprofen reduces radiation-induced angiogenic growth factor secretion of squamous cell carcinoma cell lines.
    Annals of the New York Academy of Sciences, 2004, Volume: 1030

    Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclooxygenase Inhibitors; Enzyme-Linked Immunosorbent A

2004